4 found
Order:
  1.  12
    The Use of Medical Records in Research: What Do Patients Want?Nancy E. Kass, Marvin R. Natowicz, Sara Chandros Hull, Ruth R. Faden, Laura Plantinga, Lawrence O. Gostin & Julia Slutsman - 2003 - Journal of Law, Medicine and Ethics 31 (3):429-433.
    In the past ten years, there has been growing interest in and concern about protecting the privacy of personal medical information. Insofar as medical records increasingly are stored electronically, and electronic information can be shared easily and widely, there have been legislative efforts as well as scholarly analyses calling for greater privacy protections to ensure that patients can feel safe disclosing personal information to their health-care providers. At the same time, the volume of biomedical research conducted in this country continues (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   10 citations  
  2.  23
    The Use of Medical Records in Research: What Do Patients Want?Nancy E. Kass, Marvin R. Natowicz, Sara Chandros Hull, Ruth R. Faden, Laura Plantinga, Lawrence O. Gostin & Julia Slutsman - 2003 - Journal of Law, Medicine and Ethics 31 (3):429-433.
    In the past ten years, there has been growing interest in and concern about protecting the privacy of personal medical information. Insofar as medical records increasingly are stored electronically, and electronic information can be shared easily and widely, there have been legislative efforts as well as scholarly analyses calling for greater privacy protections to ensure that patients can feel safe disclosing personal information to their health-care providers. At the same time, the volume of biomedical research conducted in this country continues (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   9 citations  
  3. Ethical Issues in Cancer Chemoprevention Trials: Considerations for IRBs and Investigators.Julia Slutsman, David Buchanan & Christine Grady - 2007 - IRB: Ethics & Human Research 29 (2):1-6.
    Cancer chemoprevention trials test the efficacy of pharmaceutical agents in preventing cancer in at-risk research subjects who are neither patients diagnosed with the disease nor typical healthy volunteers. Such trials present unique challenges to investigators and IRB reviewers when evaluating risks and benefits, assessing informed consent, and compensating subjects. Investigators and IRBs should pay particular attention to the criteria used to define at-risk subjects and carefully assess the strength of the evidence supporting them, as this is critical to evaluating the (...)
     
    Export citation  
     
    Bookmark  
  4.  1
    Implementing Single IRB Review of Multisite Research: Lessons Learned From the National Children’s Study.Julia Slutsman, Nancy Dole, Steven Leuthner & Mark S. Schreiner - 2018 - IRB: Ethics & Human Research 40 (3):14-20.
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark